VERTEX PHARMACEUTICALS INC / MA Operating Income
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Operating Income of $1.25 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA operating income (loss) for the quarter ending 2026-06-30 was $1.25B, a 8.32% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA operating income (loss) for the quarter ending 2026-03-31 was $1.14B, a 80.62% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA operating income (loss) for the quarter ending 2025-12-31 was $1.21B, a 17.53% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA operating income (loss) for the quarter ending 2025-09-30 was $1.19B, a 6.26% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA operating income (loss) for fiscal 2025 was $4.17B.
- VERTEX PHARMACEUTICALS INC / MA operating income (loss) for fiscal 2024 was -$232.90M, a 106.08% decline from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA operating income (loss) for fiscal 2023 was $3.83B, a 11.04% decline from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA operating income (loss) for fiscal 2022 was $4.31B, a 54.83% increase from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.25B 10-Q · filed 2026-08-04 | $2.38B 10-Q · filed 2026-08-04 | $3.59B derived: sum of 3 quarters · filed 2026-08-04 | $4.78B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $1.14B 10-Q · filed 2026-05-05 | $2.34B derived: sum of 2 quarters · filed 2026-05-05 | $3.53B derived: sum of 3 quarters · filed 2026-05-05 | $4.68B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $1.21B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.39B derived: sum of 2 quarters · filed 2026-02-13 | $3.54B derived: sum of 3 quarters · filed 2026-08-04 | $4.17B 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $1.19B 10-Q · filed 2025-11-04 | $2.34B derived: sum of 2 quarters · filed 2026-08-04 | $2.97B 10-Q · filed 2025-11-04 | $3.99B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $1.15B 10-Q · filed 2026-08-04 | $1.78B 10-Q · filed 2026-08-04 | $2.81B derived: sum of 3 quarters · filed 2026-08-04 | $3.92B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $630.10M 10-Q · filed 2026-05-05 | $1.66B derived: sum of 2 quarters · filed 2026-05-05 | $2.77B derived: sum of 3 quarters · filed 2026-05-05 | -$742.30M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $1.03B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.14B derived: sum of 2 quarters · filed 2026-02-13 | -$1.37B derived: sum of 3 quarters · filed 2026-02-13 | -$232.90M 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $1.12B 10-Q · filed 2025-11-04 | -$2.40B derived: sum of 2 quarters · filed 2025-11-04 | -$1.26B 10-Q · filed 2025-11-04 | -$270.40M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | -$3.51B 10-Q · filed 2025-08-05 | -$2.38B 10-Q · filed 2025-08-05 | -$1.39B derived: sum of 3 quarters · filed 2026-02-13 | -$348.60M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | $1.14B 10-Q · filed 2025-05-06 | $2.13B derived: sum of 2 quarters · filed 2026-02-13 | $3.17B derived: sum of 3 quarters · filed 2026-02-13 | $4.19B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $988.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.03B derived: sum of 2 quarters · filed 2026-02-13 | $3.05B derived: sum of 3 quarters · filed 2026-02-13 | $3.83B 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $1.04B 10-Q · filed 2024-11-05 | $2.06B derived: sum of 2 quarters · filed 2024-11-05 | $2.84B 10-Q · filed 2024-11-05 | $3.88B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $1.03B 10-Q · filed 2024-08-02 | $1.81B 10-Q · filed 2024-08-02 | $2.84B derived: sum of 3 quarters · filed 2025-02-13 | $3.97B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $779.00M 10-Q · filed 2024-05-07 | $1.81B derived: sum of 2 quarters · filed 2025-02-13 | $2.94B derived: sum of 3 quarters · filed 2025-02-13 | $4.05B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $1.03B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $2.16B derived: sum of 2 quarters · filed 2025-02-13 | $3.27B derived: sum of 3 quarters · filed 2025-02-13 | $4.31B 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $1.13B 10-Q · filed 2023-11-07 | $2.23B derived: sum of 2 quarters · filed 2023-11-07 | $3.27B 10-Q · filed 2023-11-07 | $4.15B derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $1.11B 10-Q · filed 2023-08-02 | $2.15B 10-Q · filed 2023-08-02 | $3.02B derived: sum of 3 quarters · filed 2024-02-15 | $4.08B derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $1.04B 10-Q · filed 2023-05-02 | $1.92B derived: sum of 2 quarters · filed 2024-02-15 | $2.97B derived: sum of 3 quarters · filed 2024-02-15 | $2.94B derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $877.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $1.93B derived: sum of 2 quarters · filed 2024-02-15 | $1.89B derived: sum of 3 quarters · filed 2024-02-15 | $2.78B 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $1.05B 10-Q · filed 2022-10-28 | $1.05B 10-Q · filed 2021-11-03 | $1.02B derived: sum of 2 quarters · filed 2022-10-28 | $1.90B 10-Q · filed 2022-10-28 | $1.90B 10-Q · filed 2021-11-03 | $2.65B derived: sum of 4 quarters · filed 2022-10-28 | ||
| 2021-06-30 | -$37.90M 10-Q · filed 2022-08-05 | -$37.96M 10-Q · filed 2021-07-30 | $849.90M 10-Q · filed 2022-08-05 | $849.87M 10-Q · filed 2021-07-30 | $1.60B derived: sum of 3 quarters · filed 2022-08-05 | $2.27B derived: sum of 4 quarters · filed 2022-08-05 | ||
| 2021-03-31 | $887.80M 10-Q · filed 2022-05-06 | $887.83M 10-Q · filed 2021-04-30 | $1.63B derived: sum of 2 quarters · filed 2022-05-06 | $2.31B derived: sum of 3 quarters · filed 2022-05-06 | $3.02B derived: sum of 4 quarters · filed 2022-05-06 | |||
| 2020-12-31 | $745.79M 10-K · filed 2021-02-11 | $1.42B derived: sum of 2 quarters · filed 2021-11-03 | $2.14B derived: sum of 3 quarters · filed 2021-11-03 | $2.86B 10-K · filed 2023-02-10 | $2.86B 10-K · filed 2021-02-11 | |||
| 2020-09-30 | $672.24M 10-Q · filed 2021-11-03 | $1.39B derived: sum of 2 quarters · filed 2021-11-03 | $2.11B 10-Q · filed 2021-11-03 | $2.66B derived: sum of 4 quarters · filed 2021-11-03 | ||||
| 2020-06-30 | $718.03M 10-Q · filed 2021-07-30 | $1.44B 10-Q · filed 2021-07-30 | $1.99B derived: sum of 3 quarters · filed 2021-07-30 | $2.09B derived: sum of 4 quarters · filed 2021-07-30 | ||||
| 2020-03-31 | $720.22M 10-Q · filed 2021-04-30 | $1.27B derived: sum of 2 quarters · filed 2021-04-30 | $1.37B derived: sum of 3 quarters · filed 2021-04-30 | $1.64B derived: sum of 4 quarters · filed 2021-04-30 | ||||
| 2019-12-31 | $551.47M 10-K · filed 2021-02-11 | $650.80M derived: sum of 2 quarters · filed 2021-02-11 | $920.76M derived: sum of 3 quarters · filed 2021-02-11 | $1.20B 10-K · filed 2022-02-09 | $1.20B 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $99.33M 10-K · filed 2021-02-11 | $369.29M derived: sum of 2 quarters · filed 2021-02-11 | $646.10M 10-Q · filed 2020-10-30 | $773.82M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $269.96M 10-K · filed 2021-02-11 | $546.77M 10-Q · filed 2020-07-31 | $674.49M derived: sum of 3 quarters · filed 2021-02-11 | $880.14M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $276.81M 10-K · filed 2021-02-11 | $404.53M derived: sum of 2 quarters · filed 2021-02-11 | $610.18M derived: sum of 3 quarters · filed 2021-02-11 | $783.06M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $127.72M 10-K · filed 2020-02-13 | $333.37M derived: sum of 2 quarters · filed 2020-02-13 | $506.25M derived: sum of 3 quarters · filed 2020-02-13 | $635.15M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $205.65M 10-K · filed 2020-02-13 | $378.53M derived: sum of 2 quarters · filed 2020-02-13 | $507.43M 10-Q · filed 2019-10-31 | $633.16M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $172.88M 10-K · filed 2020-02-13 | $301.78M 10-Q · filed 2019-08-01 | $427.52M derived: sum of 3 quarters · filed 2020-02-13 | $101.47M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $128.90M 10-K · filed 2020-02-13 | $254.64M derived: sum of 2 quarters · filed 2020-02-13 | -$71.41M derived: sum of 3 quarters · filed 2020-02-13 | -$18.70M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $125.74M 10-K · filed 2019-02-13 | -$200.31M derived: sum of 2 quarters · filed 2019-02-13 | -$147.60M derived: sum of 3 quarters · filed 2019-02-13 | $123.24M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | -$326.04M 10-K · filed 2019-02-13 | -$273.34M derived: sum of 2 quarters · filed 2019-02-13 | -$2.49M 10-Q · filed 2018-10-25 | $37.15M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-06-30 | $52.71M 10-K · filed 2019-02-13 | $323.55M 10-Q · filed 2018-07-26 | $363.19M derived: sum of 3 quarters · filed 2019-02-13 | $344.46M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-03-31 | $270.84M 10-K · filed 2019-02-13 | $310.48M derived: sum of 2 quarters · filed 2019-02-13 | $291.75M derived: sum of 3 quarters · filed 2019-02-13 | $295.11M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2016-12-31 | $39.64M 10-K · filed 2018-02-15 | $20.91M derived: sum of 2 quarters · filed 2018-02-15 | $24.27M derived: sum of 3 quarters · filed 2018-02-15 | $9.94M 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | -$18.73M 10-K · filed 2018-02-15 | -$15.37M derived: sum of 2 quarters · filed 2018-02-15 | -$29.70M 10-Q · filed 2017-10-30 | -$83.41M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | $3.35M 10-K · filed 2018-02-15 | -$10.98M 10-Q · filed 2017-07-28 | -$64.68M derived: sum of 3 quarters · filed 2018-02-15 | -$134.71M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | -$14.33M 10-K · filed 2018-02-15 | -$68.03M derived: sum of 2 quarters · filed 2018-02-15 | -$138.06M derived: sum of 3 quarters · filed 2018-02-15 | -$309.22M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | -$53.70M 10-K · filed 2017-02-23 | -$123.73M derived: sum of 2 quarters · filed 2017-02-23 | -$294.89M derived: sum of 3 quarters · filed 2017-02-23 | -$466.88M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | -$70.03M 10-K · filed 2017-02-23 | -$241.19M derived: sum of 2 quarters · filed 2017-02-23 | -$413.18M 10-Q · filed 2016-10-31 | -$566.80M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | -$171.16M 10-K · filed 2017-02-23 | -$343.15M 10-Q · filed 2016-08-01 | -$496.77M derived: sum of 3 quarters · filed 2017-02-23 | -$638.98M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | -$171.99M 10-K · filed 2017-02-23 | -$325.61M derived: sum of 2 quarters · filed 2017-02-23 | -$467.81M derived: sum of 3 quarters · filed 2017-02-23 | -$648.36M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | -$153.63M 10-K · filed 2016-02-16 | -$295.83M derived: sum of 2 quarters · filed 2016-02-16 | -$476.37M derived: sum of 3 quarters · filed 2016-02-16 | -$692.41M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | -$142.20M 10-K · filed 2016-02-16 | -$322.75M derived: sum of 2 quarters · filed 2016-02-16 | -$538.79M 10-Q · filed 2015-10-30 | -$549.07M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | -$180.54M 10-K · filed 2016-02-16 | -$180.84M 10-Q · filed 2014-07-31 | -$396.58M 10-Q · filed 2015-08-04 | -$397.22M 10-Q · filed 2014-07-31 | -$406.87M derived: sum of 3 quarters · filed 2016-02-16 | -$530.42M derived: sum of 4 quarters · filed 2016-02-16 | ||
| 2014-03-31 | -$216.04M 10-K · filed 2016-02-16 | -$216.39M 10-Q · filed 2014-05-05 | -$226.32M derived: sum of 2 quarters · filed 2016-02-16 | -$349.88M derived: sum of 3 quarters · filed 2016-02-16 | -$396.91M derived: sum of 4 quarters · filed 2016-02-16 | |||
| 2013-12-31 | -$10.28M 10-K · filed 2015-02-13 | -$274.16M 10-K · filed 2014-02-11 | -$133.84M derived: sum of 2 quarters · filed 2015-02-13 | -$180.87M derived: sum of 3 quarters · filed 2015-02-13 | -$610.01M 10-K · filed 2016-02-16 | -$903.45M 10-K · filed 2014-02-11 | ||
| 2013-09-30 | -$123.56M 10-K · filed 2015-02-13 | -$134.06M 10-Q · filed 2013-11-07 | -$170.59M derived: sum of 2 quarters · filed 2015-02-13 | -$599.73M 10-Q · filed 2014-11-06 | -$629.29M 10-Q · filed 2013-11-07 | -$677.20M derived: sum of 4 quarters · filed 2015-02-13 | ||
| 2013-06-30 | -$47.03M 10-K · filed 2015-02-13 | -$56.93M 10-Q · filed 2013-08-02 | -$495.22M 10-Q · filed 2014-07-31 | -$553.65M derived: sum of 3 quarters · filed 2015-02-13 | -$554.72M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-03-31 | -$429.14M 10-K · filed 2015-02-13 | -$438.29M 10-Q · filed 2013-05-08 | -$506.62M derived: sum of 2 quarters · filed 2015-02-13 | -$507.69M derived: sum of 3 quarters · filed 2015-02-13 | -$518.46M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2012-12-31 | -$77.48M 10-K · filed 2014-02-11 | -$78.55M derived: sum of 2 quarters · filed 2014-02-11 | -$89.32M derived: sum of 3 quarters · filed 2014-02-11 | $46.73M 10-K · filed 2015-02-13 | $2.33M 10-K · filed 2013-03-01 | |||
| 2012-09-30 | -$1.07M 10-K · filed 2014-02-11 | -$11.84M derived: sum of 2 quarters · filed 2014-02-11 | $79.81M 10-Q · filed 2013-11-07 | $303.71M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-06-30 | -$10.77M 10-K · filed 2014-02-11 | $80.88M 10-Q · filed 2013-08-02 | $304.78M derived: sum of 3 quarters · filed 2014-02-11 | $520.49M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-03-31 | $91.65M 10-K · filed 2014-02-11 | $315.55M derived: sum of 2 quarters · filed 2014-02-11 | $531.26M derived: sum of 3 quarters · filed 2014-02-11 | $365.37M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2011-12-31 | $223.90M 10-K · filed 2013-03-01 | $439.61M derived: sum of 2 quarters · filed 2013-03-01 | $273.72M derived: sum of 3 quarters · filed 2013-03-01 | $113.82M 10-K · filed 2014-02-11 | ||||
| 2011-09-30 | $215.71M 10-K · filed 2013-03-01 | $49.82M derived: sum of 2 quarters · filed 2013-03-01 | -$110.08M 10-Q · filed 2012-11-06 | -$276.72M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | -$165.89M 10-K · filed 2013-03-01 | -$325.79M 10-Q · filed 2012-08-08 | -$492.42M derived: sum of 3 quarters · filed 2013-03-01 | -$692.01M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | -$159.90M 10-K · filed 2013-03-01 | -$326.53M derived: sum of 2 quarters · filed 2013-03-01 | -$526.12M derived: sum of 3 quarters · filed 2013-03-01 | -$695.69M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | -$166.63M 10-K · filed 2012-02-22 | -$366.22M derived: sum of 2 quarters · filed 2012-02-22 | -$535.79M derived: sum of 3 quarters · filed 2012-02-22 | -$696.08M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | -$199.59M 10-K · filed 2012-02-22 | -$369.16M derived: sum of 2 quarters · filed 2012-02-22 | -$529.44M 10-Q · filed 2011-11-03 | -$676.16M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-06-30 | -$169.57M 10-K · filed 2012-02-22 | -$329.86M 10-Q · filed 2011-08-09 | -$476.57M derived: sum of 3 quarters · filed 2012-02-22 | -$624.81M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2010-03-31 | -$160.28M 10-K · filed 2012-02-22 | -$307.00M derived: sum of 2 quarters · filed 2012-02-22 | -$455.23M derived: sum of 3 quarters · filed 2012-02-22 | -$612.40M derived: sum of 4 quarters · filed 2012-02-22 | ||||
| 2009-12-31 | -$146.72M 10-K · filed 2011-02-17 | -$294.95M derived: sum of 2 quarters · filed 2011-02-17 | -$452.12M derived: sum of 3 quarters · filed 2011-02-17 | -$614.01M 10-K · filed 2012-02-22 | ||||
| 2009-09-30 | -$148.23M 10-K · filed 2011-02-17 | -$305.40M derived: sum of 2 quarters · filed 2011-02-17 | -$467.29M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | -$157.17M 10-K · filed 2011-02-17 | -$319.06M 10-Q · filed 2010-08-03 | ||||||
| 2009-03-31 | -$161.89M 10-K · filed 2011-02-17 | |||||||
| 2008-12-31 | -$462.71M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |